(4-(4-(4-methoxyphenylamino)pyrido[3,2-d]pyrimidin-6-yl)phenyl)(piperazin-1-yl)methanone

ID: ALA4864209

PubChem CID: 164620018

Max Phase: Preclinical

Molecular Formula: C25H24N6O2

Molecular Weight: 440.51

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Nc2ncnc3ccc(-c4ccc(C(=O)N5CCNCC5)cc4)nc23)cc1

Standard InChI:  InChI=1S/C25H24N6O2/c1-33-20-8-6-19(7-9-20)29-24-23-22(27-16-28-24)11-10-21(30-23)17-2-4-18(5-3-17)25(32)31-14-12-26-13-15-31/h2-11,16,26H,12-15H2,1H3,(H,27,28,29)

Standard InChI Key:  JVYLCRKYESJPQC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   26.1251  -24.9146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8347  -24.5052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8319  -23.6825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1233  -23.2773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4170  -24.5057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4183  -23.6891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5431  -24.9127    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5444  -25.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8360  -26.1380    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.8369  -26.9544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5500  -27.3091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2508  -26.1336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2525  -26.9449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9548  -27.3474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6560  -26.9396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6504  -26.1252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9475  -25.7264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3521  -25.7107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0630  -26.1159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7673  -25.7029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7618  -24.8848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0462  -24.4816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3449  -24.8969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4660  -24.4702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1772  -24.8728    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.4591  -23.6531    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.1794  -25.6886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8865  -26.0911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5932  -25.6800    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5881  -24.8618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8765  -24.4549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7098  -23.2818    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7083  -22.4646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  2  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 13  1  0
 12  8  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 12  2  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 16 18  1  0
 21 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
 25 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
  6 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4864209

    ---

Associated Targets(Human)

MKNK2 Tchem MAP kinase signal-integrating kinase 2 (3518 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MKNK1 Tchem MAP kinase-interacting serine/threonine-protein kinase MNK1 (2071 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 440.51Molecular Weight (Monoisotopic): 440.1961AlogP: 3.49#Rotatable Bonds: 5
Polar Surface Area: 92.27Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.82CX LogP: 3.27CX LogD: 2.70
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -1.34

References

1. Han Y, Zhang H, Wang S, Li B, Xing K, Shi Y, Cao H, Zhang J, Tong T, Zang J, Guan L, Gao X, Wang Y, Liu D, Huang M, Jing Y, Zhao L..  (2021)  Optimization of 4,6-Disubstituted Pyrido[3,2-d]pyrimidines as Dual MNK/PIM Inhibitors to Inhibit Leukemia Cell Growth.,  64  (18.0): [PMID:34515481] [10.1021/acs.jmedchem.1c01084]

Source